Navigation Links
Regenerative Medicine | Ottawa Senators Player Milan Michalek Credited Therapy For Recovery From Knee Injury
Date:1/12/2014

(PRWEB) January 12, 2014

Veteran NHL player Milan Michalek faced a decision after last season ended: surgery to repair his injured knee, or an innovative, non-invasive treatment known as platelet-rich plasma therapy. According to the Ottawa Sun on September 9,2013, Michalek declare himself fit after receiving the innovative therapy. Following the examples set by superstar athletes like Tiger Woods, Kobe Bryant and A-Rod, Michalek chose the latter, traveling to Germany to receive treatment for a week. By September, Michalek told journalists he was "100% and ready to go," and he has played thus far this season without reporting pain or re-injury.

"Such results are not uncommon," says James Hays, CEO of PlasmaGenix, Inc. "And as more and more professional athletes find relief through various forms of regenerative medicine and sing its praises, we're seeing increased interest from athletes of every skill level, as well as from patients with other orthopedic complaints."

Regenerative medicine has the potential to supercharge healing. Through a series of injections of small, concentrated amounts of a patient's own blood into damaged tissue, growth factors can speed healing and often quickly reduces or eliminates pain.

Dr. John Simmonds, an orthopedic surgeon and the Chief Medical Officer of PlasmaGenix, Inc. explains why regenerative medicine has become the treatment of choice for a wide variety of injuries and conditions: "First, before opting for surgery, it's important to explore non-invasive treatments like PRP. Second, although treating injuries and chronic conditions with medications may decrease inflammation and/or pain, such drugs are accompanied by side effects, and are often quite expensive."

PlasmaGenix has developed proprietary processes and treatments that use the power of regenerative medicine to treat joint and tendon pain, ankle sprains, heel pain, and plantar fasciitis. The Institute also uses PRP injections to improve poor circulation, treat diabetic neuropathy and HIV neuropathy.

About PlasmaGenix
PlasmaGenix is a biologics company located in Inglewood, California. Our three lead products, PlasmaNeu, PlasmaGen and PlasmaPro, have been used for over a decade to treat chronic non-healing wounds and preventing amputations in high risk populations, and? peripheral neuropathy associated with HIV and Diabetes.Science has recently shown that the body has enormous potential to heal itself. Regenerative medicine is an exciting area in medicine that is evolving very rapidly and PlasmaGenix is proud to be at the forefront of developing new therapeutics to treat a wide variety of chronic conditions. We can now deliver products to accelerate the body’s own natural healing mechanisms and enrich the body’s inherent ability to repair and regenerate.

The culmination of over 3 decades of clinical experience and research gave birth to PlasmaGenix which is poised to be a leader in the field of regenerative medicine. To date, PlasmaGenix has successfully treated over 10,000 patients for various neurologic conditions, chronic non-healing wounds, sports related injures as well as muscular sclerosis and Charcot-Marie Tooth disease.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11481480.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Growing Interest in Regenerative Medicine to Drive the Mesenchymal Stem Cells Market, According to a Soon to Be Released Report by Global Industry Analysts, Inc.
2. Startup to Strengthen Synthetic Biology and Regenerative Medicine Industries with Cutting Edge Cell Products
3. Dr. Ross Rich of Cave Creek Equine Recently Presented the Outcome of 42 Horses with Stifle Injuries Treated with Vet-Stem Regenerative Cell Therapy
4. Vet-Stem, Inc. Proudly Announces Distribution Agreement with Animal Health International, Inc. for Regenerative Cell Therapies
5. Dr. Ross Rich of Cave Creek Equine to Present at North American Veterinary Regenerative Medicine Association Conference
6. Vet-Stem, Inc. Founder and CEO, Dr. Robert Harman, to Speak at North American Veterinary Regenerative Medicine Association Conference
7. ViaCyte Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine
8. Global Stem Cells Group, Inc. Announces Worldwide Alliance with EmCyte Corp. to Promote In-office Regenerative Medicine Solutions
9. Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
10. Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference
11. The Veterinary Cooperative (TVC) and Vet-Stem, Inc. Announce an Exclusive Partnership to Offer Regenerative Medicine and Stem Cell Therapy to Over 300 Member Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Feb.10, 2016 ASAE is introducing a hybrid ... Companies (AMC) the option of joining or renewing through ... determined by staff size, every employee in any size ... and reap all available member benefits.   ... organizational membership options will allow organizations of any size ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, a ... promotion of two long-standing principal investigators (PI) to the roles of Chief Medical ... Development. , Dr. Laurence Chu, a Benchmark Research PI in the Austin office, ...
(Date:2/10/2016)... ... 10, 2016 , ... Curoverse announced today that the open-source, ... capabilities for managing and processing genomic and health data at petabyte scale. ... and analyzing genomic data,” said Adam Berrey chief executive officer at Curoverse. “Microsoft ...
(Date:2/9/2016)... LITTLE FALLS, N.J. , Feb. 9, 2016 ... ), a biotechnology company specializing in the development ... the health of damaged tissues and organs, recently ... milestones for the first quarter of 2016. ... Regenicin began the new 2015 fiscal year in ...
Breaking Biology Technology:
(Date:1/18/2016)... 18, 2016  Extenua Inc., a pioneering developer ... use and access of ubiquitous on-premise and cloud ... American Cyber.  ... transformational C4ISR and Cyber initiatives in support of ... proven technology solutions," said Steve Visconti , ...
(Date:1/13/2016)... New York , January 13, 2016 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2023. According to the ... in 2014 and is anticipated to reach US$1,625.8 mn ... 2015 to 2023. In terms of volume, the biometric ...
(Date:1/11/2016)... JOSE, Calif. , Jan. 11, 2016 ... of human interface solutions, today announced that its ClearPad ... driver integration (TDDI) products won two separate categories in ... Best Mobile Innovator and Best Technology Breakthrough. The Synaptics ... system cost, a simplified supply chain, thinner devices, brighter ...
Breaking Biology News(10 mins):